首页 › 基金 › Trustees of Columbia University in the City of New York › TARS
Trustees of Columbia University in the City of New York 对 TARS 的持仓历史
TARSUS PHARMACEUTICALS INC · 医疗保健
Trustees of Columbia University in the City of New York 在 Q3 2026 的 13F 申报中披露持有 TARS(TARSUS PHARMACEUTICALS INC)44,144 股,市值约 US$3.5M,约占其申报组合的 0.57%,在其申报持仓中市值排名第 2 位。 Trustees of Columbia University in the City of New York 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Trustees of Columbia University in the City of New York 对 TARS 的持仓演变
Trustees of Columbia University in the City of New York 于 Q3 2026 首次披露 TARS 持仓:44,144 股(约 US$3.5M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 44.14K | $3.47M | 新进 |
关于 TARS 与 13F 数据
TARS(TARSUS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 TARS,申报仓位最大的包括:Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TARS 的基金
- Deep Track Capital, LP 3.81M 股 · $299.25M · Q3 2026
- RTW INVESTMENTS, LP 3.48M 股 · $273.88M · Q3 2026
- Paradigm Biocapital Advisors LP 2.30M 股 · $180.91M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M 股 · $98.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.10M 股 · $86.17M · Q3 2026
- Vestal Point Capital, LP 1.05M 股 · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K 股 · $45.86M · Q2 2026
- TCG Crossover Management, LLC 388.16K 股 · $30.51M · Q3 2026
- Rock Springs Capital Management LP 285.12K 股 · $22.41M · Q3 2026
更多关于 Trustees of Columbia University in the City of New York
常见问题
How long has Trustees of Columbia University in the City of New York held TARS?
Trustees of Columbia University in the City of New York has disclosed TARS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Trustees of Columbia University in the City of New York's current position in TARS?
As of Q3 2026, Trustees of Columbia University in the City of New York holds 44.14K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $3.47M, representing 0.57% of its reported portfolio and ranking #2.
Has Trustees of Columbia University in the City of New York been buying or selling TARS?
In the latest 13F filing (Q3 2026), Trustees of Columbia University in the City of New York newly opened its position in TARS.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.